Rurangirwa F R, Stiller D, French D M, Palmer G H
Program in Vector-Borne Diseases, Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164-7040, USA.
Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3171-6. doi: 10.1073/pnas.96.6.3171.
Anaplasma marginale is an ehrlichial pathogen of cattle that establishes lifelong persistent infection. Persistence is characterized by rickettsemic cycles in which new A. marginale variant types, defined by the sequence of the expressed msp2 transcripts, emerge. The polymorphic msp2 transcripts encode structurally distinct MSP2 proteins and result in an antigenically diverse and continually changing A. marginale population within the blood. In this manuscript, we used sequence analysis of msp2 transcripts to show that a restricted repertoire of variant types, designated SGV1 and SGV2, is expressed within the tick salivary gland. The same SGV1 and SGV2 variant types were expressed in ticks regardless of the variant types expressed in the blood of infected cattle at the time of acquisition feeding by the ticks. Importantly, subsequent tick transmission to susceptible cattle resulted in acute rickettsemia composed of organisms expressing only the same SGV1 and SGV2 variant types. This indicates that the msp2 expressed by organisms within the tick salivary gland predicts the variant type responsible for acute rickettsemia and disease. This restriction of transmitted A. marginale variant types, in contrast to the marked diversity within persistently infected cattle, supports development of MSP2 vaccines to prevent acute rickettsemia in tick-transmitted infections.
边缘无形体是牛的一种埃立克体病原体,可建立终身持续感染。持续性感染的特征是出现立克次体血症周期,在此期间,由表达的msp2转录本序列定义的新的边缘无形体变异类型会出现。多态性msp2转录本编码结构不同的MSP2蛋白,并导致血液中边缘无形体群体在抗原性上多样化且不断变化。在本手稿中,我们通过对msp2转录本进行序列分析,发现蜱唾液腺内表达的变异类型有限,命名为SGV1和SGV2。无论蜱在获取血液时感染牛血液中表达的变异类型如何,蜱中表达的都是相同的SGV1和SGV2变异类型。重要的是,随后蜱将病原体传播给易感牛会导致急性立克次体血症,其病原体仅表达相同的SGV1和SGV2变异类型。这表明蜱唾液腺内病原体表达的msp2可预测导致急性立克次体血症和疾病的变异类型。与持续感染牛体内显著的多样性相比,这种传播的边缘无形体变异类型的限制支持开发MSP2疫苗以预防蜱传播感染中的急性立克次体血症。